Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.750
+0.050 (2.94%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
2.30M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.17M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Tivic Health Systems | 482.00K |
| iTonic Holdings | 305.22K |
AEMD News
- 3 days ago - Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th - GlobeNewsWire
- 14 days ago - Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 - PRNewsWire
- 18 days ago - Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 24 days ago - Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update - PRNewsWire
- 4 weeks ago - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026 - PRNewsWire
- 3 months ago - Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million - PRNewsWire
- 3 months ago - Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs - PRNewsWire